XML 70 R57.htm IDEA: XBRL DOCUMENT v3.3.1.900
Sale of Sumavel DosePro Business - Net Assets and Calculation of Gain on Sale (Details) (Details) - USD ($)
$ in Thousands
12 Months Ended
May. 16, 2014
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Imputed interest on working capital advance   $ 4,615    
Net gain on sale of business   89,484 $ 79,980 $ 0
Sumavel DosePro [Member]        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Non-contingent consideration received $ 89,624      
Imputed interest on working capital advance 4,748      
Carrying value of Sumavel DosePro inventory on hand at Closing (4,624)      
Transaction costs (660)   (660)  
Deferred revenue associated with undelivered elements (9,108) $ (7,083) (8,535)  
Net gain on sale of business $ 79,980   $ 79,980